Pain and the placebo effect

Biobehavioral Approaches to Pain

Volumn , Issue , 2009, Pages 65-84

  Pollo, Antonella ^a   Benedetti, Fabrizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879603925     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-78323-9_4     Document Type: Chapter

References (84)

1. Ader, R. (1997). The role of conditioning in pharmacotherapy. In: Harrington, A. (Ed.). The placebo effect: An interdisciplinary exploration (pp. 138-165). Cambridge, MA: Harvard University Press.
2. Ader, R., & Cohen, N. (1982). Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science, 215:1534-1536.
3. Amanzio, M., & Benedetti, F. (1999). Neuropharmacological dissection of placebo analgesia: Expectation-activated 7/26/2008 3:28AMopioid systems versus conditioning-activated specific sub-systems. Journal of Neuroscience, 19:484-494.
4. Amanzio, M., Pollo, A., Maggi, G., & Benedetti, F. (2001). Response variability and to analgesics: A role for non-specific activation of endogenous opioids. Pain, 90:205-215.
5. Andre, J., Zeau, B., Pohl, M., Cesselin, F., Benoliel, J. J., & Becker, C. (2005). Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioural and biochemical studies. Journal of Neuroscience. 25:7896-7904.
6. Bausell, R. B., Lao, L., Bergman, S., Lee, W. L., & Berman, B. M. (2005). Is acupuncture analgesia an expectancy effect? Evaluation and The Health Professions, 215:9-26.
7. Bencherif, B., Fuchs, P. N., Sheth, R., Dannals, R. F., Campbell, J. N., & Frost, J. J. (2002). Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain, 215:589-598.
8. Benedetti, F. (1996). The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain, 215:535-543.
9. Benedetti, F. (2002). How the doctor's words affect the patient's brain. Evaluation and The Health Professions, 215:369-386.
10. Benedetti, F., Amanzio, M., & Maggi, G. (1995). Potentiation of placebo analgesia by proglumide. Lancet, 215:1231.
11. Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997). Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain, 215:135-140.
12. Benedetti, F., Arduino, C., & Amanzio, M. (1999a). Somatotopic activation of opioid systems by target-directed expectations of analgesia. Journal of Neuroscience, 215:3639-3648.
13. Benedetti, F., Amanzio, M., Baldi, S., Casadio, C., & Maggi, G. (1999b). Inducing placebo respiratory depressant responses in humans via opioid receptors. European Journal of Neuroscience, 215:625-631.
14. Benedetti, F., Maggi, G., Lopiano, L., Lanotte, M., Rainero, I., Vighetti, S., et al. (2003). Open versus hidden medical treatments: The patient's knowledge about a therapy affects the therapy outcome. Prevention and Treatment. http://content2.apa.org/journals/pre/6/1/1
15. Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003). Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. Journal of Neuroscience, 23:4315-4323.
16. Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. Journal of Neuroscience, 215:12014-12022.
17. Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., et al. (2006). Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain, 215:133-144.
18. Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007) When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience, 215:260-271.
19. Bingel, U., Lorenz, J., Schoell, E., Weiller, C., & Büchel, C. (2006). Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain, 215:8-15.
20. Brody, H. (2000). The placebo response. New York. Harper Collins.
21. Charron, J., Rainville, P., & Marchand, S. (2006). Direct comparison of placebo effects on clinical and experimental pain. Clinical Journal of Pain 22:204-211.
22. Colloca, L., & Benedetti, F. (2005). Placebos and painkillers: is mind as real as matter? Nature Reviews Neuroscience, 215:545-552.
23. Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004). Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurology, 3:679-684.
24. Davis, C. E. (2002). Regression to the mean or placebo effect? In: Guess, H. A., Kleinman, A., Kusek, J. W., & Engel, L. W. (Eds.), The science of the placebo: Toward an interdisciplinary research agenda (pp. 158-166). London: BMJ Books.
25. Di Blasi, Z., Harkness, E., Ernst, E., Georgiou, A., & Kleijnen, J. (2001). Influence of context effect on health outcomes: A systematic review. Lancet 357:757-762.
26. Dworkin, S. F., Chen, A. C., Le Resche, L., & Clark, D. W. (1983). Cognitive reversal of expected nitrous oxide analgesia for acute pain. Anesthesia and Analgesia, 215:1073-1077.
27. Fields, H. (2004). State-dependent opioid control of pain. Nature Reviews Neuroscience, 215:565-575.
28. Fields, H. L., & Levine, J. D. (1984). Placebo analgesia - a role for endorphins? Trends Neuroscience, 215:271-273.
29. Giang, D. W., Goodman, A. D., Schiffer, R. B., Mattson, D. H., Petrie, M., Cohen, N., et al. (1996). Conditioning of cyclophosphamide-induced leukopenia in humans. Journal of Neuropsychiatry and Clinical Neurosciences, 215:194-201.
30. Goebel, M. U., Trebst, A. E., Steiner, J., Xie, Y. F., Exton, M. S., Frede, S., et al. (2002). Behavioral conditioning of immunosuppression is possible in humans. FASEB Journal, 215:1869-1873.
31. Gracely, R. H., Dubner, R., Wolskee, P. J., & Deeter, W. R. (1983). Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature, 215:264-265.
32. Gracely, R. H., Dubner, R., Deeter, W. D., & Wolskee, P. J. (1985). Clinician's expectations influence placebo analgesia. Lancet, 215:43.
33. Grevert, P., Albert, L. H., & Goldstein, A. (1983). Partial antagonism of placebo analgesia by naloxone. Pain, 215:129-143.
34. Hahn, R. A. (1985). A sociocultural model of illness and healing. In: White, L., Tursky, B., & Schwartz, G. E. (Eds.), Placebo: Theory, research and mechanisms (pp. 167-195). New York: Guilford.
35. Hebb, A. L. O., Poulin, J. F., Roach, S. P., Zacharko, R. M. & Drolet, G. (2005). Cholecystokinin and endogenous opioid peptides: Interactive influence on pain, cognition and emotion. Progress in Neuropsychopharmacology and Biological Psychiatry, 215:1225-1238.
36. Hrobjartsson, A., & Gotzsche, P. C. (2001). Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine, 215:1594-1602.
37. Hughes, J. (1975). Search for the endogenous ligand of the opiate receptor. Neuroscience Research Program Bulletin, 215:55-58.
38. Keltner, J. R., Furst, A., Fan, C., Redfern, R., Inglis, B., & Fields, H. L. (2006). Isolating the modulatory effect of expectation on pain transmission: a functional magnetic imaging study. Journal of Neuroscience, 215:4437-4443.
39. Kirsch, I. (1985). Response expectancy as a determinant of experience and behavior. American Psychological, 40:1189-1202.
40. Kirsch, I. (1990). Changing expectations: A key to effective psychotherapy. Pacific Grove, CA: Brooks-Cole.
41. Kirsch, I. (Ed) (1999). How expectancies shape experience. Washington, DC: American Psychological Association.
42. Kissel, P., & Barrucand, D. (1964). Placébos et effet-placébo en médicine. Paris: Masson.
43. Kong, J., Gollub, R. L., Rosman, I. S., Webb, J. M., Vangel, M. G., Kirsch, I., et al. (2006). Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. Journal of Neuroscience, 215:381-388.
44. Koyama, T., Tanaka, Y. Z., & Mikami, A. (1998). Nociceptive neurons in the macaque anterior cingulate activate during anticipation of pain. Neuroreport, 9:2663-2667.
45. Koyama, T., McHaffie, J. G., Laurienti, P. J., & Coghill, R. C. (2005). The subjective experience of pain: Where expectations become reality. Proceedings of National Academy of Science, 215:12950-12955.
46. Levine, J. D., & Gordon, N. C. (1984). Influence of the method of drug administration on analgesic response. Nature, 215:755-756.
47. Levine, J. D., Gordon, N. C., & Fields, H. L. (1978). The mechanisms of placebo analgesia. Lancet, 2:654-657.
48. Linde, K., Witt, C. M., Streng, A., Weidenhammer, W., Wagenpfeil, S., Brinkhous, B., et al. (2007). The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain, 215:264-271.
49. Lipman, J. J., Miller, B. E., Mays, K. S., Miller, M. N., North, W. C., & Byrne, W. L. (1990). Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response. Psychopharmacology, 102:112-6.
50. Lorenz, J., Hauch, M., Paur, R. C., Nakamura, Y., Zimmermann, R., Bromm, B., et al. (2005). Cortical correlates of false expectations during pain intensity judgments - A possible manifestation of placebo/nocebo cognitions. Brain Behavior, and Immunity, 19:283-295.
51. Lydiard, R. B. (1994). Neuropeptides and anxiety: Focus on cholecystokinin. Clinical Chemistry, 215:315-318.
52. Matre, D., Casey, K. L., & Knardahl, S. (2006). Placebo-induced changes in spinal cord pain processing. Journal of Neuroscience, 215:559-63.
53. Millan, M. J. (2002). Descending control of pain. Progress in Neurobiology, 215:355-474.
54. Moerman, D. E. (2002). Meaning, medicine and the placebo effect. Cambridge, MA. Cambridge University Press.
55. Montgomery, G. H., & Kirsch, I. (1997). Classical conditioning and the placebo effect. Pain, 215:107-113.
56. Noble, F., & Roques, B. P. (2003). The role of CCK2 receptors in the homeostasis of the opioid system. Drugs Today, 215:897-908.
57. Pacheco-Lopez, G., Engler, H., Niemi, M. B., & Schedlowski, M. (2006). Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain Behavavior, and Immunity, 20:430-446.
58. Pariente, J., White, P., Frackowiak, R. S. J., & Lewith, G. (2005). Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. NeuroImage, 215:1161-1167.
59. Pert, C. B., & Snyder, S. H. (1973). Opiate receptor: Demonstration in nervous tissue. Science, 215:1011-1013.
60. Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002). Placebo and opioid analgesia-Imaging a shared neuronal network. Science, 215:1737-1740.
61. Pollo, A., Amanzio, M., Arslanian, A., Casadio, C., Maggi, G., & Benedetti, F. (2001). Response expectancies in placebo analgesia and their clinical relevance. Pain, 215:77-83.
62. Pollo, A., Vighetti, S., Rainero, I., & Benedetti, F. (2003). Placebo analgesia and the heart. Pain, 215:125-133.
63. Porro, C. A., Baraldi, P., Pagnoni, G., Serafini, M., Facchin, P., Maieron, M., et al. (2002). Does anticipation of pain affect cortical nociceptive systems? Journal of Neuroscience, 215:3206-3214.
64. Porro, C. A., Cettolo, V., Francescano, M. P., & Baraldi, P. (2003). Functional activity mapping of the mesial hemispheric wall durino anticipation of pain. Neuroimage, 215:1738-1747.
65. Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H., & Nicholls, S. S. (1999). An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain, 215:147-156.
66. Price, D. D., Craggs, J., Verne, G. N., Perlstein, W. M., & Robinson, M. E. (2007). Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain, 215:63-72.
67. Reiss, S. (1980). Pavlovian conditioning and human fear: An expectancy model. Behavior Therapy, 215:380-396.
68. Rescorla, R. A. (1988). Pavlovian conditioning: it is not what you think it is. American Psychologist, 215:151-160.
69. Reynolds, D. V. (1969). Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science, 215:444-445.
70. Sawamoto, N., Honda, M., Okada, T., Hanakawa, T., Kanda, M., Fukuyama, H., et al. (2000). Expectation of pain enhances responses to nonpainful somatosensory stimulation in the anterior cingulated cortex and parietal operculum/posterior insula: an eventrelated functional magnetic resonance imaging study. Journal of Neuroscience, 215:7438-7445.
71. Siegel, S. (1985). Drug anticipatory responses in animals. In: White, L., Tursky, B., & Schwartz, G. E. (Eds.) Placebo: Theory, research and mechanisms (pp. 288-305). New York: Guilford Press.
72. Siegel, S. (2002). Explanatory mechanisms for placebo effects: Pavlovian conditioning. In: Guess, H. A., Kleinman, A., Kusek, J. W, & Engel, L. W. (Eds.), The Science ofthe Placebo: Toward an Interdisciplinary Research Agenda (pp. 133-157). London: BMJ Books.
73. Thorn, B. (2007). Commentaries on the placebo concept in psychotherapy. Journal of Clinical Psychology, 215:371-372.
74. Vase, L., Riley, J. L. 3rd, & Price, D. D. (2002). A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain, 215:443-452.
75. Vase, L., Robinson, M. E., Verne, G. N., & Price, D. D. (2005). Increased placebo analgesia over timein irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain, 215:338-347.
76. Voudouris, N. J., Peck, C. L., & Coleman, G. (1985). Conditioned placebo responses. Journal of Personality and Social Psychology, 215:47-53.
77. Voudouris, N. J., Peck, C. L., & Coleman, G. (1989). Conditioned response models of placebo phenomena: further support. Pain, 215:109-116.
78. Voudouris, N. J., Peck, C. L., & Coleman, G. (1990). The role of conditioning and verbal expectancy in the placebo response. Pain, 215:121-128.
79. Wager, T. D., Rilling, J. K., Smith, E. E., Sokolik, A., Casey, K. L., Davidson, R. J., et al. (2004). Placebo-induced changes in fMRI in the anticipation and experience of pain. Science, 215:1162-1166.
80. Wager, T. D., Matre, D., & Casey, K. L. (2006). Placebo effects in laser-evoked pain potentials. Brain Behavior, and Immunity, 215:219-230.
81. Wampold, B. E., Minami, T., Callen Tierney, S., Baskin, T. W., & Bhati, K. S. (2005). The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials. Journal of Clinical Psychology, 61:835-854.
82. Wikramasekera, I. (1985). A conditioned response model of the placebo effect: predictions of the model. In: White, L., Tursky, B., & Schwartz, G. E. (Eds.), Placebo: Theory, research and mechanisms. New York: Guilford Press.
83. Zubieta, J. K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., et al. (2005). Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. Journal of Neuroscience, 215:7754-7762.
84. Zubieta, J. K., Yau, W. Y., Scott, D. J., & Stohler, C. S. (2006). Belief or need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain Behavior, and Immunity, 215:15-26.